FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11422411000001107: Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
41043801000001114 Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
42073301000001116 Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (PLIVA Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Is a Mitoxantrone 20mg/10ml solution for injection vials true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Has active ingredient Mitoxantrone hydrochloride false Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Mitoxantrone true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Has specific active ingredient Mitoxantrone hydrochloride true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Has active ingredient Mitoxantrone true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Has basis of strength substance Mitoxantrone true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) 1 vial Is pack of False Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) 1 vial Has AMP True Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pliva Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start